Literature DB >> 8132373

A case of rhinoscleroma cured with ciprofloxacin.

M Trautmann1, T Held, M Ruhnke, N Schnoy.   

Abstract

The diagnosis of rhinoscleroma was confirmed in a 17-year-old female patient from Tehran, Iran, suffering from a roundish tumour of the nose. Prior treatment with streptomycin and tetracycline had been unsuccessful. A three-month course of high-dose oral ciprofloxacin (750 mg b.i.d.) led to prompt cessation of the growth of the granuloma which was removed later by plastic surgery. Although serology alone appeared to have little value for the specific diagnosis of rhinoscleroma, a significant increase of IgG antibodies during treatment with ciprofloxacin confirmed infection by Klebsiella rhinoscleromatis in this case.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8132373     DOI: 10.1007/bf01728925

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  A NOTE ON THE GEOGRAPHICAL DISTRIBUTION OF SCLEROMA.

Authors:  A L WAHI; R N MISRA
Journal:  J Laryngol Otol       Date:  1964-06       Impact factor: 1.469

2.  Scleroma in Guatemala, with a study of the disease based on the experience of 108 cases.

Authors:  J QUEVEDO
Journal:  Ann Otol Rhinol Laryngol       Date:  1949-09       Impact factor: 1.547

Review 3.  Epidemiology of Klebsiella and hospital-associated infections.

Authors:  J Z Montgomerie
Journal:  Rev Infect Dis       Date:  1979 Sep-Oct

4.  Rhinoscleroma as a cause of airway obstruction.

Authors:  S N Goldberg; R F Canalis
Journal:  Ear Nose Throat J       Date:  1980-04       Impact factor: 1.697

5.  Enzyme-linked immunospecific antibody test for detecting antibody to Klebsiella.

Authors:  J P Rissing; T B Buxton; W L Moore; T Ozawa; W L Moore
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

6.  Enzyme-linked immunosorbent assay to evaluate the immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.

Authors:  M Granström; B Wretlind; B Markman; S Cryz
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

7.  Scleroma (Rhinoscleroma). A histologic immunohistochemical study with bacteriologic correlates.

Authors:  P R Meyer; T K Shum; T S Becker; C R Taylor
Journal:  Arch Pathol Lab Med       Date:  1983-07       Impact factor: 5.534

8.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

9.  Uptake of ciprofloxacin by macrophages.

Authors:  C S Easmon; J P Crane
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

10.  Clinical update on rhinoscleroma.

Authors:  T K Shum; C W Whitaker; P R Meyer
Journal:  Laryngoscope       Date:  1982-10       Impact factor: 3.325

View more
  2 in total

Review 1.  Rhinoscleroma: a case series report and review of the literature.

Authors:  B K Mukara; P Munyarugamba; S Dazert; J Löhler
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-01       Impact factor: 2.503

Review 2.  Ciprofloxacin safety in paediatrics: a systematic review.

Authors:  Abiodun Adefurin; Helen Sammons; Evelyne Jacqz-Aigrain; Imti Choonara
Journal:  Arch Dis Child       Date:  2011-07-23       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.